Danaher
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 3
- OptoSeeker Extends Instruments Toward AI-Assisted Wet Labs
36氪 reports that OptoSeeker is combining self-developed life-science instruments, AI models, laboratory automation, hardware-software coordination, and data capabilities to explore intelligent wet-lab solutions. Its commercial OptoBot 1000 integrates optical tweezers, microfluidics, imaging, and automated control, while the company is also developing a life-science agent and has reported partnerships spanning AI models, sequencing, and omics services. The report describes deployments and financing, but its single-source, company-profile format leaves performance and commercialization claims unverified.
36氪 人工智能 · 🔥 0 - Danaher to launch AI autonomous lab with up to 8x faster antibody reagent development
Danaher announced it will launch its first AI-powered autonomous research lab, based at its reagent subsidiary Abcam and combining AI, robotics and technologies from subsidiaries including Beckman Coulter Life Sciences, Cytiva, Genedata, Integrated DNA Technologies and Molecular Devices, with instrument coordination and robotic automation co-developed with Automata, which Danaher invested in during January 2026; full-scale operation is expected in early 2027. In the loop, AI first designs affinity reagents such as antibodies that bind biological targets, robots build and test them, and results are fed back to the models to improve the next design round. Danaher says the approach can speed up the path from concept to validated reagent by up to 8x and lift annual reagent output up to 10x, from dozens to hundreds of reagents — figures that are the company's own projections.
科技新报 · 🔥 0 - Musk builds chips, Zuckerberg farms cells as AI races for new means of production
The piece argues the AI race is shifting from hoarding GPUs to controlling two physical inputs: chip fabrication and biological experimental data. Musk's SpaceX and Tesla announced in August a Texas "Terafab" chip manufacturing base with $16.8 billion in first-phase investment, while Zuckerberg-backed Biohub joined an approximately $1.8 billion virtual biology initiative announced on Oct. 7 that aims to turn labs into pipelines that continuously generate training data. It also cites Anthropic's Bay Area wet lab, where Claude proposes experiments, and Danaher's plan to run its first AI autonomous research lab at scale by early 2027.
虎嗅 AI · 🔥 0
Experience and discussion from the community
Share my Danaher experienceAsk about Danaher
Nobody has shared their experience with Danaher yet.